TransCode Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 75,683 | $25,641 | -1.13% | 0.03% |
| SHEETS SMITH WEALTH MANAGEMENT | 05/26/2023 | 60,000 | $20,310 | 140.00% | 0.02% |
| ONE68 GLOBAL CAPITAL, LLC | 05/15/2023 | 30,120 | $10,196 | 100.00% | 0.01% |
| STATE STREET CORP | 05/15/2023 | 21,019 | $7,121 | 0.00% | 0.01% |
| WARBERG ASSET MANAGEMENT LLC | 05/15/2023 | 20,000 | $6,770 | 100.00% | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2023 | 19,407 | $6,569 | 0.00% | 0.01% |
| SHAY CAPITAL LLC | 05/15/2023 | 15,060 | $5,098 | 0.00% | 0.01% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 13,122 | $4,442 | -23.36% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/09/2023 | 6,351 | $2,000 | 0.00% | 0.00% |
| BLACKROCK INC. | 05/12/2023 | 1,385 | $469 | -91.17% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/12/2023 | 51 | $17 | 2.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/15/2023 | 0 | $0 | 0.00% | 0.00% |
| MORGAN STANLEY | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/01/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| TRIUMPH CAPITAL MANAGEMENT | 05/08/2023 | 0 | $0 | -100.00% | 0.00% |
| CAHILL WEALTH MANAGEMENT, LLC | 05/08/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TransCode Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of TransCode Therapeutics, Inc.. The most heavily invested institutionals were:
ACT CAPITAL MANAGEMENT, LLC: 6,500
0.09% of TransCode Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6,500 shares in the last 24 months. This purchase volume represents approximately $22,685 in transactions.